Skip to main content

Languages

  • العربية
  • 简体中文
  • English
  • Français
  • Русский
  • Español
Home
  • Browse States Parties
  • CBM Guide
    • English
    • Chinese
    • French
    • Russian
    • Spanish
    • Arabic
  • Log in

You are here

Home » Canada » bwc_cbm_2019_Canada_Fr » Confidence-Building Measure G
Download

    Conseil national de recherches du Canada

    2. Location (mailing address)
    Ottawa (Ontario)
    3. General description of the types of diseases covered

    Fabricant de vaccins destinés aux essais cliniques chez les humains

    Report Index

    • Cover page declaration (“Form 0”)
    • A, part 1
    • A, part 2 (i)
    • A, part 2 (ii)
    • A, part 2 (iii)
    • B
    • C
    • E
    • F
    • G
        • Corporation ID Biomédical du Québec (GlaxoSmithKline Inc.)
        • Sanofi Pasteur Limited
        • Immunovaccine
        • Medicago
        • InventVac
        • Artemis Technologies Inc. (Perm. can. établ. prod. biol. vét. No 50)
        • Biovet Inc. (Perm. can. établ. prod. biol. vét. No 49)
        • Centre for Aquaculture Technologies Canada (Can. Vet. Biol. Estab. Lic. No. 61)
        • Ceva Animal Health (Perm. can. établ. prod. biol. vét. N° 23)
        • Elanco Canada Limited - Aqua Health (Perm. can. établ. prod. biol. vét. N° 40)
        •  
        • 1 of 2
        • next ›

    BWC Electronic Confidence Building Measures Portal

    Copyright (c) UNOG 2018

     

    Biological Weapons Convention Implementation Support Unit

    Palais des Nations, 1211 Geneva 10, Switzerland
    Phone: +41 (0)22 917 2230
    E-mail: bwc@un.org
    UNOG logo